May 10, 2016 – May 12, 2016
Immatics at CIMT Annual Meeting 2016 in Mainz, Germany

Meet people from Immatics at the Annual Meeting of the Association of Cancer Immunotherapy (CIMT), the largest cancer immunotherapy meeting in Europe! Immatics will also be presenting:

Tuesday, May 10

3pm – 5.30pm

On- and off target toxicity profiling for adoptive cell therapy by mass spectrometry-based immunopeptidome analysis of primary human normal tissues

Oliver Schoor, Immatics Biotechnologies Tuebingen, Germany

Session: Cellular Therapy

Type: Poster

Location: Rheingoldhalle Congress Center Mainz, Foyer

Wednesday, May 11

10.30am – 10.45am

On- and off target toxicity profiling for adoptive cell therapy by mass spectrometry-based immunopeptidome analysis of primary human normal tissues

Oliver Schoor, Immatics Biotechnologies Tuebingen, Germany

Session: Cellular Therapy

Type: Talk

Location: Rheingoldhalle Congress Center Mainz, Congress Hall

Wednesday, May 11

4.45pm – 5.05pm

GAPVAC: first results from a personalized peptide vaccination study in glioblastoma

Harpreet Singh, Immatics Biotechnologies Tuebingen, Germany

Session: EU Consortia Session

Type: Talk

Location: Rheingoldhalle Congress Center Mainz, Gutenberg A

For further information please do not hesitate to contact us!

For more information on CIMT 2016: click

For more information on the GAPVAC EU consortium: click

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back